Latest News
Hispanic Community Perspectives on Clinical Trial Participation
Hispanic individuals remain critically underrepresented in clinical trials, despite being one of the fastest-growing demographic groups in the United States. This underrepresentation exacerbates healthcare disparities and limits the generalizability of research findings.
Research Articles
Preparing Sites to Be Diverse Capable During Site Selection
With the recent passing of the Omnibus Spending Package, in 2023 the FDA will now make...
TOTAL Diversity’s Response to FDA’s Draft Guidance to Industry Regarding Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials
Total Diversity Clinical Trial Management (TOTAL, Dallas Texas) supports efforts to...
A Determination of Variables That Impact Research Site Best Practices: An Analysis of Clinical Trial Site Characteristics as Compared to Scores Using the SCRS Diversity Self-Assessment Tool (DSAT)
By Diana Foster, Ph.D., CEO, TOTAL Diversity Clinical Trial Management, Kim Kundert,...
Identify Opportunities to Improve Diversity Recruitment
Diana Foster, Ph.D.CEO, Total Diversity Clinical Trials Management While it's important...
Diversity and Inclusion in Clinical Trials
Diana Foster, Ph.D.CEO, Total Diversity Clinical Trials Management One of the most...
The Diversity Site Assessment Tool (DSAT), Reliability and Validity of the Industry Gold Standard for Establishing Investigator Site Ranking
Diana Foster, Ph.D. Vice President, Strategy and Special Projects, Society of...